HFCAS OpenIR

浏览/检索结果: 共98条,第1-10条 帮助

已选(0)清除 条数/页:   排序方式:
Predicting and overcoming resistance to CDK9 inhibitors for cancer therapy 期刊论文
ACTA PHARMACEUTICA SINICA B, 2023, 卷号: 13
作者:  Hua, Chen;  Shena, Lijuan;  Zoua, Fengming;  Wua, Yun;  Wanga, Beilei;  Wanga, Aoli;  Wud, Chao;  Wanga, Li;  Liua, Jing;  Wanga, Wenchao;  Liua, Qingsong
收藏  |  浏览/下载:42/0  |  提交时间:2023/11/10
Acquired resistance mutations  CDK9 inhibitors  Transcription  Single nucleotide polymorphisms  BAY1251152  
Differentiation of renal angiomyolipoma without visible fat from small clear cell renal cell carcinoma by using specific region of interest on contrast-enhanced CT: a new combination of quantitative tools 期刊论文
CANCER IMAGING, 2021, 卷号: 21
作者:  Wang, Xu;  Song, Ge;  Jiang, Haitao
收藏  |  浏览/下载:69/0  |  提交时间:2021/08/31
一种薄膜样品全自动裁切方法与装置 专利
专利类型: 发明专利, 专利号: ZL201910879174.2, 申请日期: 2021-03-02,
发明人:  花昌义;  李志刚;  叶超;  王善锋;  孙淼;  吴浩;  吴晓松;  张龙;  刘勇
收藏  |  浏览/下载:36/0  |  提交时间:2021/12/14
Network-based analysis with primary cells reveals drug response landscape of acute myeloid leukemia 期刊论文
EXPERIMENTAL CELL RESEARCH, 2020, 卷号: 393
作者:  Chen, Cheng;  Wang, Li;  Li, Lili;  Wang, Aoli;  Huang, Tao;  Hu, Jie;  Zhao, Ming;  Liu, Feiyang;  Qi, Shuang;  Hu, Chen;  Wang, Wenliang;  Liu, Jing;  Ge, Jian;  Xia, Ruixiang;  Wang, Wenchao;  Liu, Qingsong
收藏  |  浏览/下载:43/0  |  提交时间:2020/11/26
Acute myeloid leukemia (AML)  Drug response  Gene mutations  
新型高通量体外药敏检测技术在复发难治性急性髓系白血病患者个体化用药中的应用 期刊论文
肿瘤防治研究, 2020, 卷号: 47
-
收藏  |  浏览/下载:32/0  |  提交时间:2020/10/26
Drug sensitivity  AML  High-throughput  HDS  药敏  急性髓系白血病  高通量  HDS  
Discovery of N-(4-(6-Acetamidopyrimidin-4-yloxy)phenyl)-2-(2-(trifluoromethyl)phenyl)acetamide (CHMFL-FLT3-335) as a Potent FMS-like Tyrosine Kinase 3 Internal Tandem Duplication (FLT3-ITD) Mutant Selective Inhibitor for Acute Myeloid Leukemia 期刊论文
JOURNAL OF MEDICINAL CHEMISTRY, 2019, 卷号: 62, 期号: 2, 页码: 875-892
作者:  Liang, Xiaofei;  Wang, Beilei;  Chen, Cheng;  Wang, Aoli;  Hu, Chen;  Zou, Fengming;  Yu, Kailin;  Liu, Qingwang;  Li, Feng;  Hu, Zhenquan;  Lu, Tingting;  Wang, Junjie;  Wang, Li;  Weisberg, Ellen L.;  Li, Lili;  Xia, Ruixiang;  Wang, Wenchao;  Ren, Tao;  Ge, Jian;  Liu, Jing;  Liu, Qinsong
浏览  |  Adobe PDF(13868Kb)  |  收藏  |  浏览/下载:378/323  |  提交时间:2020/05/21
合肥梅雨季节大气污染物分布特征的激光雷达探测 期刊论文
中国激光, 2019, 卷号: 000
作者:  方欣;  王敏;  胡顺星
收藏  |  浏览/下载:76/0  |  提交时间:2020/10/26
大气光学  消光系数  激光雷达  气溶胶  臭氧  梅雨季节  
Discovery of (E)-N-(4-((4-methylpiperazin-1-yl)methyl)-3-(trifluoromethyl)phenyl)-3-((3-(2-(pyridin-2-yl)vinyl)-1H-indazol-6-yl)thio)propanamide (CHMFL-ABL-121) as a highly potent ABL kinase inhibitor capable of overcoming a variety of ABL mutants including T315I for chronic myeloid leukemia 期刊论文
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2018, 卷号: 160, 页码: 61-81
作者:  Liu, Xuesong;  Wang, Beilei;  Chen, Cheng;  Jiang, Zongru;  Hu, Chen;  Wu, Hong;  Zhang, Yicong;  Liu, Xiaochuan;  Wang, Wenliang;  Wang, Junjie;  Hu, Zhenquan;  Wang, Aoli;  Huang, Tao;  Liu, Qingwang;  Wang, Wei;  Wang, Li;  Wang, Wenchao;  Ren, Tao;  Li, Lili;  Xia, Ruixiang;  Ge, Jian;  Liu, Qingsong;  Liu, Jing
Adobe PDF(4593Kb)  |  收藏  |  浏览/下载:198/104  |  提交时间:2019/01/11
ABL kinase  Kinase inhibitor  ABL mutant  CML  
Discovery of (S)-2-amino-N-(5-(6-chloro-5-(3-methylphenylsulfonamido)pyridin-3-yl)-4-methylthiazol-2-yl)-3-methylbutanamide (CHMFL-PI3KD-317) as a potent and selective phosphoinositide 3-kinase delta (PI3K delta) inhibitor 期刊论文
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2018, 卷号: 156, 页码: 831-846
作者:  Liang, Xiaofei;  Li, Feng;  Chen, Cheng;  Jiang, Zongru;  Wang, Aoli;  Liu, Xiaochuan;  Ge, Juan;  Hu, Zhenquan;  Yu, Kailin;  Wang, Wenliang;  Zou, Fengming;  Liu, Qingwang;  Wang, Beilei;  Wang, Li;  Zhang, Shanchun;  Wang, Yuxin;  Liu, Qingsong;  Liu, Jing
收藏  |  浏览/下载:60/0  |  提交时间:2019/12/10
PI3K delta  Kinase inhibitor  Acute myeloid leukemia  Structure-activity relationship  
Venetoclax and low-dose cytarabine induced complete remission in a patient with high-risk acute myeloid leukemia: a case report 期刊论文
FRONTIERS OF MEDICINE, 2018, 卷号: 12
-
收藏  |  浏览/下载:30/0  |  提交时间:2020/10/26
BCL-2 INHIBITOR  MIDOSTAURIN  CLASSIFICATION  DECITABINE  MECHANISMS  MUTATIONS  TARGETS  IDH  BTK  venetoclax  cytarabine  AML  leukemia